Investigating the health risks and causes of overdose deaths related to methamphetamine injection.
Methamphetamine injection, associated health risk, and causes of overdose deaths.
This study is looking at why people inject methamphetamine and how it relates to using fentanyl and the risk of infections, especially in cities like San Francisco and Oakland, to better understand the health dangers and overdose deaths in these communities.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project ID | NIH-10886684 on NIH RePORTER |
What this research studies
This research focuses on understanding the motivations behind methamphetamine injection and its association with fentanyl use and infectious disease risks. It aims to explore how these factors contribute to overdose deaths in urban areas like San Francisco and Oakland, California. By analyzing data and conducting interviews, the study seeks to provide updated insights into the health risks faced by individuals who inject methamphetamine, particularly in the context of the current opioid epidemic.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults over 21 years old who inject methamphetamine and may also be using fentanyl.
Not a fit: Patients who do not use methamphetamine or fentanyl, or those under 21 years old, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for individuals at risk of methamphetamine-related health issues and overdose.
How similar studies have performed: Previous research has successfully characterized health risks associated with methamphetamine use, but this study aims to address the novel challenges posed by the co-use of fentanyl.
Where this research is happening
Research Triangle Park, United States
- Research Triangle Institute — Research Triangle Park, United States (Active)
Researchers
- Principal investigator: Kral, Alexander H — Research Triangle Institute
- Study coordinator: Kral, Alexander H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.